• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[从肾脏病学家的角度看对透析通路的要求]

[Demands on dialysis access from the nephrologists point of view].

作者信息

Ott U, Sperschneider H

机构信息

KfH-Nierenzentrum Jena, Zur Lämmerlaide 1, 07751 Jena, Germany.

出版信息

Chirurg. 2012 Sep;83(9):775-8. doi: 10.1007/s00104-012-2302-1.

DOI:10.1007/s00104-012-2302-1
PMID:22968423
Abstract

Vascular access is the lifeline of hemodialysis patients. The superiority of autogenous arteriovenous fistulas compared to prostethic arteriovenous grafts or a central venous catheter is well established. Fistulas have a far lower risk of failure and a reduced requirement for revision compared to prosthetic grafts. Alternative vascular access can be achieved via a prosthetic graft or permanent central venous catheter but the risk of infection is increased. The most important complications are shunt thrombosis, stenosis, aneurysms or steal syndrome. Signs of these complications should be recognized by the dialysis team and early surgical intervention can avoid major complications. In many cases a complex shunt is necessary if the patient has been on dialysis for a long time. Interaction between the dialysis team, nephrologists, surgeons and interventional radiologists can improve the prognosis of dialysis patient.

摘要

血管通路是血液透析患者的生命线。自体动静脉内瘘相较于人工动静脉移植物或中心静脉导管的优越性已得到充分证实。与人工移植物相比,内瘘的失败风险要低得多,且修复需求也减少。可通过人工移植物或永久性中心静脉导管实现替代血管通路,但感染风险会增加。最重要的并发症是分流血栓形成、狭窄、动脉瘤或窃血综合征。透析团队应识别出这些并发症的体征,早期手术干预可避免严重并发症。在许多情况下,如果患者长期接受透析,则需要一个复杂的分流。透析团队、肾病学家、外科医生和介入放射科医生之间的协作可以改善透析患者的预后。

相似文献

1
[Demands on dialysis access from the nephrologists point of view].[从肾脏病学家的角度看对透析通路的要求]
Chirurg. 2012 Sep;83(9):775-8. doi: 10.1007/s00104-012-2302-1.
2
[Central venous catheters as access for acute and long-term dialysis].[中心静脉导管作为急性和长期透析的血管通路]
Chirurg. 2012 Sep;83(9):801-8. doi: 10.1007/s00104-012-2306-x.
3
[Vascular grafts as access for hemodialysis].[用于血液透析通路的血管移植物]
Chirurg. 2012 Sep;83(9):785-92. doi: 10.1007/s00104-012-2304-z.
4
Utilization, patency, and complications associated with vascular access for hemodialysis in the United States.美国血液透析血管通路的利用、通畅性和相关并发症。
J Vasc Surg. 2018 Oct;68(4):1166-1174. doi: 10.1016/j.jvs.2018.01.049.
5
Integrated approach to construction and maintenance of prosthetic arteriovenous access for hemodialysis.用于血液透析的人工动静脉通路构建与维护的综合方法。
Vascular. 2004 Jul-Aug;12(4):243-55. doi: 10.1258/rsmvasc.12.4.243.
6
Hemodialysis access in the pediatric patient population.儿科患者群体中的血液透析通路
Am J Surg. 1994 Aug;168(2):197-201. doi: 10.1016/s0002-9610(94)80067-7.
7
Complications in Percutaneous Dialysis Interventions: How to Avoid Them, and How to Treat Them When They do Occur.经皮透析干预的并发症:如何避免以及发生时如何治疗。
Tech Vasc Interv Radiol. 2017 Mar;20(1):58-64. doi: 10.1053/j.tvir.2016.11.009. Epub 2016 Nov 29.
8
Vascular access of last resort.终极血管通路。
Kidney Int. 2018 Apr;93(4):797-802. doi: 10.1016/j.kint.2017.10.030. Epub 2018 Feb 21.
9
Current state of dialysis access management in Korea.韩国透析通路管理的现状。
J Vasc Access. 2019 May;20(1_suppl):15-19. doi: 10.1177/1129729818776913.
10
Bilateral central vein stenosis: options for dialysis access and renal replacement therapy when all upper extremity access possibilities have been lost.双侧中心静脉狭窄:当所有上肢建立通路的可能性均已丧失时,透析通路及肾脏替代治疗的选择。
J Vasc Access. 2014 Nov-Dec;15(6):466-73. doi: 10.5301/jva.5000268. Epub 2014 Jul 10.

引用本文的文献

1
Neutrophil extracellular traps and heparin-induced antibodies contribute to vascular access thrombosis in hemodialysis patients.中性粒细胞胞外诱捕网和肝素诱导的抗体促成血液透析患者的血管通路血栓形成。
Kidney Res Clin Pract. 2021 Dec;40(4):712-723. doi: 10.23876/j.krcp.21.080. Epub 2021 Aug 6.

本文引用的文献

1
Timing of arteriovenous fistula placement and Medicare costs during dialysis initiation.动静脉瘘管放置时机与透析起始时的医疗保险费用。
Am J Nephrol. 2012;35(6):498-508. doi: 10.1159/000338518. Epub 2012 May 11.
2
Dialysis access dysfunction.透析通路功能障碍
Int J Nephrol. 2012;2012:612025. doi: 10.1155/2012/612025. Epub 2012 Apr 12.
3
Antiplatelet therapy and vascular-access patency.抗血小板治疗与血管通路通畅性。
N Engl J Med. 2009 May 21;360(21):2240-2. doi: 10.1056/NEJMe0902841.
4
Effect of dipyridamole plus aspirin on hemodialysis graft patency.双嘧达莫加阿司匹林对血液透析移植物通畅性的影响。
N Engl J Med. 2009 May 21;360(21):2191-201. doi: 10.1056/NEJMoa0805840.
5
Vascular access use in Europe and the United States: results from the DOPPS.欧美地区血管通路的使用情况:透析预后与实践模式研究(DOPPS)的结果
Kidney Int. 2002 Jan;61(1):305-16. doi: 10.1046/j.1523-1755.2002.00117.x.
6
Predictors of adequacy of arteriovenous fistulas in hemodialysis patients.血液透析患者动静脉内瘘成熟度的预测因素
Kidney Int. 1999 Jul;56(1):275-80. doi: 10.1046/j.1523-1755.1999.00515.x.